false
--12-31
Q2
2026-06-30
0001941189
http://fasb.org/us-gaap/2026#IncomeTaxExpenseBenefit
http://fasb.org/us-gaap/2026#IncomeTaxExpenseBenefit
0001941189
2026-01-01
2026-06-30
0001941189
2026-06-30
0001941189
2025-12-31
0001941189
us-gaap:NonrelatedPartyMember
2026-06-30
0001941189
us-gaap:NonrelatedPartyMember
2025-12-31
0001941189
us-gaap:RelatedPartyMember
2026-06-30
0001941189
us-gaap:RelatedPartyMember
2025-12-31
0001941189
us-gaap:NonrelatedPartyMember
2026-01-01
2026-06-30
0001941189
us-gaap:NonrelatedPartyMember
2025-01-01
2025-06-30
0001941189
us-gaap:RelatedPartyMember
2026-01-01
2026-06-30
0001941189
us-gaap:RelatedPartyMember
2025-01-01
2025-06-30
0001941189
2025-01-01
2025-06-30
0001941189
us-gaap:CommonStockMember
2024-12-31
0001941189
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001941189
us-gaap:RetainedEarningsMember
2024-12-31
0001941189
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001941189
2024-12-31
0001941189
us-gaap:CommonStockMember
2025-12-31
0001941189
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001941189
us-gaap:RetainedEarningsMember
2025-12-31
0001941189
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001941189
us-gaap:CommonStockMember
2025-01-01
2025-12-31
0001941189
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-12-31
0001941189
us-gaap:RetainedEarningsMember
2025-01-01
2025-12-31
0001941189
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-12-31
0001941189
2025-01-01
2025-12-31
0001941189
us-gaap:CommonStockMember
2026-01-01
2026-06-30
0001941189
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-06-30
0001941189
us-gaap:RetainedEarningsMember
2026-01-01
2026-06-30
0001941189
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-06-30
0001941189
us-gaap:CommonStockMember
2026-06-30
0001941189
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0001941189
us-gaap:RetainedEarningsMember
2026-06-30
0001941189
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0001941189
2025-06-30
0001941189
TANAF:TiananTechnologyGroupLtdMember
2026-01-01
2026-06-30
0001941189
TANAF:TiananTechnologyGroupLtdMember
2026-06-30
0001941189
TANAF:TiananTechnologyGroupHKLimitedMember
2026-01-01
2026-06-30
0001941189
TANAF:TiananTechnologyGroupHKLimitedMember
2026-06-30
0001941189
TANAF:ShanghaiQigePowerTechnologyCoLtdMember
2026-01-01
2026-06-30
0001941189
TANAF:ShanghaiQigePowerTechnologyCoLtdMember
2026-06-30
0001941189
TANAF:HenanQigePowerArtificialIntelligenceTechnologyCoLtdMember
2026-01-01
2026-06-30
0001941189
TANAF:HenanQigePowerArtificialIntelligenceTechnologyCoLtdMember
2026-06-30
0001941189
TANAF:YearEndedRMBUSDExchangeRateMember
2026-06-30
0001941189
TANAF:YearEndedRMBUSDExchangeRateMember
2025-06-30
0001941189
TANAF:RMBUSDAverageAnnualExchangeRateMember
2026-06-30
0001941189
TANAF:RMBUSDAverageAnnualExchangeRateMember
2025-06-30
0001941189
TANAF:YearEndedRMBUSDExchangeRateMember
2025-12-31
0001941189
TANAF:RMBUSDAverageAnnualExchangeRateMember
2025-12-31
0001941189
TANAF:YearEndedHKDUSDExchangeRateMember
2026-06-30
0001941189
TANAF:YearEndedHKDUSDExchangeRateMember
2025-06-30
0001941189
TANAF:HKDUSDAverageAnnualExchangeRateMember
2026-06-30
0001941189
TANAF:HKDUSDAverageAnnualExchangeRateMember
2025-06-30
0001941189
TANAF:YearEndedHKDUSDExchangeRateMember
2025-12-31
0001941189
TANAF:HKDUSDAverageAnnualExchangeRateMember
2025-12-31
0001941189
TANAF:SingleSegmentMember
2026-01-01
2026-06-30
0001941189
TANAF:SingleSegmentMember
2025-01-01
2025-06-30
0001941189
TANAF:Mr.HengFeiYangMember
2026-01-01
2026-06-30
0001941189
TANAF:Mr.HengFeiYangMember
2025-01-01
2025-06-30
0001941189
TANAF:Mr.HengFeiYangMember
2026-06-30
0001941189
TANAF:Mr.HengFeiYangMember
2025-12-31
0001941189
2022-07-12
0001941189
2022-07-13
0001941189
TANAF:SixtySixIndividualMember
2022-08-22
2022-08-22
0001941189
TANAF:MrGangWangMember
2023-10-26
2023-10-26
0001941189
TANAF:MrLihongZouMember
2023-12-25
2023-12-25
0001941189
2024-01-01
2024-12-31
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerAMember
2026-01-01
2026-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerAMember
2025-01-01
2025-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerBMember
2026-01-01
2026-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerBMember
2025-01-01
2025-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerCMember
2026-01-01
2026-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerCMember
2025-01-01
2025-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerDMember
2026-01-01
2026-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerDMember
2025-01-01
2025-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerEMember
2026-01-01
2026-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerEMember
2025-01-01
2025-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerFMember
2026-01-01
2026-06-30
0001941189
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
TANAF:CustomerFMember
2025-01-01
2025-06-30
0001941189
TANAF:TotalPurchasesMember
us-gaap:SupplierConcentrationRiskMember
TANAF:SuppliersAAMember
2026-01-01
2026-06-30
0001941189
TANAF:TotalPurchasesMember
us-gaap:SupplierConcentrationRiskMember
TANAF:SuppliersAAMember
2025-01-01
2025-06-30
0001941189
TANAF:TotalPurchasesMember
us-gaap:SupplierConcentrationRiskMember
TANAF:SuppliersBBMember
2026-01-01
2026-06-30
0001941189
TANAF:TotalPurchasesMember
us-gaap:SupplierConcentrationRiskMember
TANAF:SuppliersBBMember
2025-01-01
2025-06-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
TANAF:Segments
iso4217:CNY
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of August 2026
Commission
File Number 333-267453
TIAN’AN
TECHNOLOGY GROUP LTD.
(Translation
of registrant’s name into English)
10th
Floor, Building 5
No.
525 Yuanjiang Road, Minhang District
Shanghai,
China
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
On
August 19, 2026, Tian’an Technology Group Ltd. (the “Company”) released its unaudited condensed interim consolidated
statements of financial position for the 6-month period ended on June 30, 2026 and related footnotes, which are set forth below:
TIAN’AN
TECHNOLOGY GROUP LTD. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
| | |
As of
June 30, 2026 | | |
As of
December 31, 2025 | |
| | |
(Unaudited) | | |
| |
| ASSETS | |
| | | |
| | |
| | |
| | | |
| | |
| Current Assets: | |
| | | |
| | |
| Cash | |
$ | 130,337 | | |
$ | 49,864 | |
| Restricted cash | |
| 15,603 | | |
| - | |
| Accounts receivable | |
| - | | |
| 17,537 | |
| Inventories | |
| - | | |
| 8,747 | |
| Advances to suppliers | |
| 21,461 | | |
| 507,725 | |
| | |
| | | |
| | |
| TOTAL ASSETS | |
$ | 167,401 | | |
$ | 583,873 | |
| | |
| | | |
| | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
| | |
| | | |
| | |
| Current Liabilities: | |
| | | |
| | |
| Accounts payable | |
$ | 396 | | |
$ | 5,017 | |
| Payroll payable | |
| 11,950 | | |
| 14,156 | |
| Taxes payable | |
| 4,400 | | |
| 5,207 | |
| Advance from customers | |
| - | | |
| 12,955 | |
| Due to related parties | |
| 196,268 | | |
| 537,724 | |
| Other payables | |
| 36,030 | | |
| 80,589 | |
| | |
| | | |
| | |
| Total Current Liabilities | |
| 249,044 | | |
| 655,648 | |
| | |
| | | |
| | |
| Commitments and Contingencies | |
| - | | |
| - | |
| | |
| | | |
| | |
| Stockholders’ Equity: | |
| | | |
| | |
| Common Stock, No par value, 100,000,000 shares authorized; 45,518,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |
| - | | |
| - | |
| Additional paid-in capital | |
| 607,200 | | |
| 607,200 | |
| Accumulated deficits | |
| (707,565 | ) | |
| (699,689 | ) |
| Other comprehensive loss | |
| 18,722 | | |
| 20,714 | |
| | |
| | | |
| | |
| Total Stockholders’ Equity | |
| (81,643 | ) | |
| (71,775 | ) |
| | |
| | | |
| | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | |
$ | 167,401 | | |
$ | 583,873 | |
The
accompanying notes are an integral part of these consolidated financial statements
TIAN’AN
TECHNOLOGY GROUP LTD. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Revenue | |
$ | 433,784 | | |
$ | 460,939 | |
| Revenue - related parties | |
| - | | |
| 10,259 | |
| Total Revenue | |
| 433,784 | | |
| 471,198 | |
| | |
| | | |
| | |
| Cost of revenue | |
| 316,938 | | |
| 300,395 | |
| Cost of revenue - related parties | |
| - | | |
| 7,925 | |
| Total Cost of revenue | |
| 316,938 | | |
| 308,320 | |
| | |
| | | |
| | |
| Gross profit | |
| 116,846 | | |
| 162,878 | |
| | |
| | | |
| | |
| Operating Expenses: | |
| | | |
| | |
| Selling and marketing | |
| 24,952 | | |
| 26,860 | |
| General and administrative | |
| 98,678 | | |
| 115,390 | |
| | |
| | | |
| | |
| Total operating expenses | |
| 123,630 | | |
| 142,250 | |
| | |
| | | |
| | |
| Income (loss) from operations | |
| (6,784 | ) | |
| 20,628 | |
| | |
| | | |
| | |
| Other Income (Loss): | |
| | | |
| | |
| Interest income, net | |
| 38 | | |
| 25 | |
| Other expense, net | |
| (1,130 | ) | |
| (538 | ) |
| Other loss, net | |
| (1,092 | ) | |
| (513 | ) |
| | |
| | | |
| | |
| | |
| | | |
| | |
| Income taxes | |
| - | | |
| - | |
| Net income (loss) | |
| (7,876 | ) | |
| 20,115 | |
| Other Comprehensive Income (Loss): | |
| | | |
| | |
| Foreign currency translation adjustment | |
| (1,992 | ) | |
| 320 | |
| | |
| | | |
| | |
| Comprehensive income (loss) | |
$ | (9,868 | ) | |
$ | 20,435 | |
| | |
| | | |
| | |
| Earnings (Loss) per common share, basic and diluted | |
$ | (0.00 | ) | |
$ | 0.00 | |
| | |
| | | |
| | |
| Weighted average number of shares outstanding, basic and diluted | |
| 45,518,000 | | |
| 45,518,000 | |
The
accompanying notes are an integral part of these consolidated financial statements
TIAN’AN
TECHNOLOGY GROUP LTD. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
| | |
Number of
Shares | | |
Common
Stock | | |
Paid-in
Capital | | |
Accumulated Deficits | | |
Comprehensive Income (Loss) | | |
Total | |
| | |
Common Stock | | |
Additional | | |
| | |
Other | | |
| |
| | |
Number of
Shares | | |
Common
Stock | | |
Paid-in
Capital | | |
Accumulated Deficits | | |
Comprehensive Income (Loss) | | |
Total | |
| Balance at December 31, 2024 | |
| 45,518,000 | | |
| - | | |
| 607,200 | | |
| (609,758 | ) | |
| 22,586 | | |
| 20,028 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| (89,931 | ) | |
| - | | |
| (89,931 | ) |
| Foreign currency translation adjustment | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,872 | ) | |
| (1,872 | ) |
| Balance at December 31, 2025 | |
| 45,518,000 | | |
| - | | |
| 607,200 | | |
| (699,689 | ) | |
| 20,714 | | |
| (71,775 | ) |
| Balance | |
| 45,518,000 | | |
| - | | |
| 607,200 | | |
| (699,689 | ) | |
| 20,714 | | |
| (71,775 | ) |
| Net loss | |
| - | | |
| - | | |
| - | | |
| (7,876 | ) | |
| - | | |
| (7,876 | ) |
| Foreign currency translation adjustment | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,992 | ) | |
| (1,992 | ) |
| Balance at June 30, 2026 | |
| 45,518,000 | | |
$ | - | | |
$ | 607,200 | | |
$ | (707,565 | ) | |
$ | 18,722 | | |
$ | (81,643 | ) |
| Balance | |
| 45,518,000 | | |
$ | - | | |
$ | 607,200 | | |
$ | (707,565 | ) | |
$ | 18,722 | | |
$ | (81,643 | ) |
The
accompanying notes are an integral part of these consolidated financial statements
TIAN’AN
TECHNOLOGY GROUP LTD. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Unaudited)
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | | |
| | |
| Net Income (Loss) | |
$ | (7,876 | ) | |
$ | 20,115 | |
| Adjustments to Reconcile Net Income (Loss) to Net Cash Used in Operating Activities: | |
| | | |
| | |
| Accounts receivable | |
| 17,792 | | |
| (20,239 | ) |
| Accounts receivable - related party | |
| - | | |
| 14,437 | |
| Other receivables | |
| - | | |
| (5,725 | ) |
| Inventories | |
| 8,875 | | |
| (25,854 | ) |
| Advances to suppliers | |
| 493,923 | | |
| 178,059 | |
| Accounts payable | |
| (4,686 | ) | |
| 1,124 | |
| Advance from customers | |
| (13,085 | ) | |
| (100,986 | ) |
| Payroll payable | |
| (2,548 | ) | |
| 4,159 | |
| Taxes payable | |
| (934 | ) | |
| (13,904 | ) |
| Other payables | |
| (46,164 | ) | |
| (53,783 | ) |
| | |
| | | |
| | |
| Net Cash Used in Operating Activities | |
| 445,297 | | |
| (2,597 | ) |
| | |
| | | |
| | |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
| Proceeds from related parties | |
| 42,360 | | |
| 41,266 | |
| Repayments to related parties | |
| (393,442 | ) | |
| (157,185 | ) |
| | |
| | | |
| | |
| Net Cash Provided by (Used in) Financing Activities | |
| (351,082 | ) | |
| (115,919 | ) |
| | |
| | | |
| | |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
| Purchase of fixed assets | |
| - | | |
| - | |
| | |
| | | |
| | |
| Net Cash Used in Investing Activities | |
| - | | |
| - | |
| | |
| | | |
| | |
| Effect Of Exchange Rate Changes On Cash | |
| 1,861 | | |
| (1,009 | ) |
| | |
| | | |
| | |
| Net increase (decrease) in Cash, cash equivalents and restricted cash | |
| 96,076 | | |
| (119,525 | ) |
| Cash, cash equivalents and restricted cash, beginning of period | |
| 49,864 | | |
| 133,479 | |
| | |
| | | |
| | |
| Cash, cash equivalents and restricted cash, end of period | |
$ | 145,940 | | |
$ | 13,954 | |
| | |
| | | |
| | |
| Supplemental Disclosure of
Cash Flow Information: | |
| | | |
| | |
| Interest | |
$ | 38 | | |
$ | 25 | |
| Income taxes | |
$ | - | | |
$ | - | |
The
accompanying notes are an integral part of these consolidated financial statements
TIAN’AN
TECHNOLOGY GROUP LTD. AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE
1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The
accompanying consolidated financial statements encompass the financial data of Tian’an Technology Group Ltd. (“Tian’an”),
a holding company incorporated in the British Virgin Islands on April 8, 2021; Tian’an Technology Group (HK) Limited (“Tian’an
HK”), formerly known as Yunke Jingrong Information Technology Co., Ltd., established in Hong Kong on October 27, 2021; Shanghai
Qige Power Technology Co., Ltd. (“Shanghai Qige”), an operating company incorporated in the People’s Republic of China
(the “PRC”) on August 10, 2016; and Henan Qige Power Artificial Intelligence Technology Co., Ltd. (“Henan Qige”),
an operating company incorporated in the PRC on September 25, 2024. Shanghai Qige and Henan Qige are wholly owned subsidiaries of Tian’an
HK, which, in turn, is a wholly owned subsidiary of Tian’an. Collectively, these entities are referred to as “the Company.”
Currently,
the Company’s operations are conducted exclusively through its subsidiaries, Tian’an HK, Shanghai Qige and Henan Qige,
while Tian’an functions solely as a holding company without direct operations.
Initially, through Shanghai Qige, the Company specialized in technology-driven sales of power control and service systems solutions.
However, in the third quarter of 2022, it transitioned its business model to focus on graphene production and the health therapy
industry. The Company leverages the far-infrared heat therapy properties of graphene, integrating them into its products.
In
the third quarter of 2024, the Company expanded its business by establishing Henan Qige as a wholly owned subsidiary in China to enter
the healthcare service sector. Additionally, plans are underway to develop an online medicine distribution platform to facilitate medication
delivery for customers.
Tian’an
is a holding company with no substantive operations. Tian’an HK historically functioned as a holding company; however, beginning
in 2025, Tian’an HK commenced limited sales activities. Notwithstanding such activities, substantially all of the Company’s
operations continue to be conducted through its PRC subsidiaries.
The
Company’s initial marketing efforts are in the Eastern China market with the intention of developing a nationwide marketing network.
SCHEDULE
OF CONSOLIDATED COMPANIES
Name of Consolidated
Companies | |
Domicile and Date of
Incorporation | |
Paid in
Capital | |
Percentage of
Effective
Ownership | |
Principal
Activities |
| Tian’an Technology Group Ltd. | |
April 8, 2021, British Virgin Islands | |
USD $0 | |
89% owned by Mr. Heng Fei Yang | |
Investment holding |
| Tian’an Technology Group (HK) Limited (formerly known as Yunke Jingrong Information Technology Co., Ltd.) | |
October 27, 2021, Hong Kong | |
USD $0 | |
100% owned by Tian’an | |
Investment holding and limited sales of healthcare products |
| Shanghai Qige Power Technology Co., Ltd. | |
August 10, 2016, PRC | |
USD $0 | |
100% owned by Tian’an HK | |
Sales of healthcare products |
| Henan Qige Power Artificial Intelligence Technology Co., Ltd. | |
September 25, 2024, PRC | |
RMB $100,000 | |
100% owned by Tian’an HK | |
Artificial intelligence software development and healthcare services |
Basis
of Presentation and Principles of Consolidation
The
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America (“US GAAP”) and include the Company and its wholly-owned subsidiaries. The functional currencies of
the Company and its subsidiaries are the currencies of the primary economic environments in which they operate, principally the
Chinese Renminbi (“RMB”) and Hong Kong dollar (“HKD”). The Company’s reporting currency is the United
States dollar (“USD”). All significant inter-company accounts and transactions have been eliminated in
consolidation. The consolidated financial statements include all adjustments that, in the opinion of management, are necessary
to make the financial statements not misleading.
Use
of Estimates and Assumptions
The
preparation of financial statements in conformity with US GAAP requires Management to make estimates and judgments that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements, and the reported
amounts of revenues and expenses during the reporting period.
Management
bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable
under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly,
these estimates may change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s
operating environment changes. Significant estimates and assumptions by Management include, among others, revenue recognition, valuation
of inventory, the determination of allowances for credit losses of financial assets, including other receivables
and prepayments, as applicable. While Management believes that the estimates and assumptions used in the preparation of the financial
statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and
the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.
Concentrations
of Business and Credit Risks
Substantially all
of the Company’s operations are located in the PRC. There can be no assurance that the Company will be able to successfully continue
to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results
of operations and cash flows. Moreover, the success of the Company’s operations is subject to numerous contingencies, some of which
are beyond management’s control. These contingencies include, but are not limited to, general economic conditions,
prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company’s
operations are primarily conducted in the PRC, the Company is subject to various additional political, economic and other uncertainties.
Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, customs regulations,
changing taxation policies, foreign exchange restrictions, and political and governmental regulations. The Company operates in China,
which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between
United States dollars (“USD”) and the Chinese currency Renminbi (“RMB”).
Statements
of Cash Flows
The
Company prepares its consolidated statements of cash flows in accordance with FASB ASC Topic 230, Statement of Cash Flows. The
statements of cash flows present the cash effects during periods of the Company’s operating, investing and financing
activities and reconcile net income (loss) to net cash provided by (used in) operating activities. Cash flows from the Company’s
operations are calculated based upon the functional currencies and translated to the reporting currency using an average foreign exchange
rate for the reporting period. As a result, amounts related to assets and liabilities reported in the statements of cash flows will not
necessarily be the same as the corresponding balances on the consolidated balance sheets. For purposes of the consolidated statement
of cash flows, the Company considers all highly liquid investments with original maturities of three months or less when purchased to
be cash equivalents. The consolidated statements of cash flows explain the change during the period in the total of cash, cash equivalents
and restricted cash. Transfers between cash, cash equivalents and restricted cash are not presented as operating, investing or financing
activities in the consolidated statements of cash flows.
The
following table provides a reconciliation of cash, cash equivalents, and restricted cash reported in the consolidated balance sheets
to the total amounts presented in the consolidated statements of cash flows.
SCHEDULE
OF RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH REPORTED IN THE CONSOLIDATED BALANCE SHEETS
| | |
As of
June 30,
2026 | | |
As of
December 31,
2025 | |
| Cash | |
$ | 130,337 | | |
$ | 49,864 | |
| Cash equivalents | |
| - | | |
| - | |
| Restricted cash | |
| 15,603 | | |
| - | |
| Total cash, cash equivalents and restricted cash shown in the consolidated
statements of the cash flows | |
$ | 145,940 | | |
$ | 49,864 | |
Cash
Cash
consists
primarily of cash on hand and cash in banks which is readily available in checking and savings
accounts with financial institutions. The Company maintains cash with various financial institutions in the PRC. Deposits with
qualifying PRC banking institutions are generally covered by the PRC deposit insurance system up to the applicable statutory limit. Cash
balances in excess of the insured limit are subject to credit risk. The Company has not experienced any losses from funds held in
bank accounts and monitors the credit quality of the financial institutions with which it maintains its deposits.
Restricted
Cash
Amounts
included in restricted cash represent cash that is temporarily unavailable for the Company’s use due to restrictions imposed by
a financial institution pending the completion of account closure and fund remittance procedures. As of June 30, 2026, restricted cash
of $15,603 represented
the remaining balance in the Company’s bank account with Hang Seng Bank Limited following the closure of the account on May 26,
2026. The funds remained subject to the bank’s account settlement and remittance procedures as of June 30, 2026. Upon completion
of those procedures, the funds were transferred to the Company’s newly opened bank account with Oversea-Chinese Banking
Corporation Limited on July 6, 2026.
Advances
to Suppliers
The
Company periodically makes advance payments to
certain vendors for purchases of raw materials or to service providers for services to be rendered and
records these payments as advances to suppliers. As of June 30, 2026 and December 31, 2025, advances to suppliers amounted to $21,461
and $507,725,
respectively.
Inventories
Inventories
are stated at the lower of cost or net realizable value. The Company uses the weighted average cost method of accounting for inventories.
The Company regularly evaluates the composition of its inventories to identify slow-moving and obsolete inventories to determine whether
valuation allowance is required. As of June 30, 2026 and December 31, 2025, the Company
reported inventories of $0 and
$8,747 without
inventory valuation allowance.
Leases
The
Company leases office space from third parties. In accordance with FASB ASC Topic 842, the Company recognizes a right-of-use
asset and a corresponding lease liability at the commencement date of the lease contract and recognizes in profit or loss
the lease cost or expense during the lease term, except for leases that qualify for the short-term lease exemption. The Company
has elected not to recognize right-of-use assets and lease liabilities for leases with an initial term of
12 months or less and no purchase option that the Company is reasonably certain to exercise. Lease payments for such short-term leases
are recognized as lease expense on a straight-line basis over the lease term.
Lease
liabilities are measured at the present value of lease payments over the lease term using the rate implicit in the lease, if readily
determinable. If the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rate. Renewal
options are included in the lease term when the Company is reasonably certain to exercise such options. Variable lease payments that
are not included in the measurement of lease liabilities are recognized as expense in the period in which the obligation for those payments
is incurred.
Variable
lease payments include payments to lessors for taxes, maintenance, insurance and other operating costs as well as payments that are adjusted
based on an index or rate. The Company’s lease agreements do not contain any significant residual value guarantees or restrictive
covenants.
Revenue
Recognition
The
Company adopted Accounting Standards Codification (“ASC”) Topic 606, Revenues from Contract with Customers (“ASC
606”) for all periods presented. Under ASC 606, revenue is recognized when control of the promised goods or services is transferred
to the Company’s customers, in an amount that reflects the consideration that the Company expects to be entitled in exchange for
those goods or services, net of value-added tax. The Company determines revenue recognition through the following steps:
| ● | Identify
the contract with a customer; |
| ● | Identify
the performance obligations in the contract; |
| ● | Determine
the transaction price; |
| ● | Allocate
the transaction price to the performance obligations in the contract; and |
| ● | Recognize
revenue when (or as) the entity satisfies a performance obligation. |
The
transaction price is allocated to each performance obligation based on the relative standalone selling prices of the goods or services
underlying each performance obligation. The transaction price allocated to each performance obligation is recognized when the Company
satisfies that performance obligation by transferring control of the promised goods or services to the customer, which may occur
at a point in time or over time, as appropriate.
For
the six months ended June 30, 2026 and 2025, the Company’s revenues were primarily derived from the sale of intelligent graphene
moxibustion devices in the People’s Republic of China (“PRC”). Revenue from the sale of these products is recognized
at a point in time when control of the products is transferred to the customer, which generally occurs upon physical delivery of the
products to and acceptance by the customer. The Company’s sales during these periods were primarily made to customers located in
the PRC.
The
Company’s revenues are net of value added
tax (“VAT”) collected on behalf of PRC tax authorities in respect to the sales of merchandise. VAT collected from customers,
net of VAT paid for purchases, is recorded as a liability in the accompanying consolidated balance sheets until it is paid to the relevant
PRC tax authorities.
Fair
Value of Financial Instruments
The
Company measures its financial and non-financial assets
and liabilities, as well as makes related disclosures, in accordance with FASB ASC Topic 820, Fair Value Measurement (“ASC
820”), which provides guidance with respect to valuation techniques to be utilized in the
determination of fair value of assets and liabilities. Approaches include, (i) the market approach (comparable market prices), (ii) the
income approach (present value of future income or cash flow), and (iii) the cost approach (cost to replace the service capacity of an
asset or replacement cost). ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value into three broad levels. The following is a brief description of those three levels:
Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level
2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
Level
3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such
as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
Earnings (Loss)
per Common Share
The
basic earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the weighted average
number of common shares during the period. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available
to common shareholders by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number
of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. For the six months
ended June 30, 2026 and 2025, the Company had no potential dilutive common stock equivalents outstanding.
Income
Taxes
The
Company and its subsidiaries are subject to income taxes in the jurisdictions in which they are organized or operate. The Company accounts
for income taxes in accordance with FASB ASC Topic 740, Income Taxes (ASC 740),
which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future
tax consequences of events that have been recognized in the Company’s financial statements or tax returns. ASC 740 additionally
requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets. Realization of deferred
tax assets is dependent upon future earnings, if any, of which the timing and amount are uncertain.
According
to ASC 740, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not
that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical
merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the
amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater
than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not
recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions
that no longer meet the more-likely-than-not criteria should be derecognized in the first subsequent financial reporting period in which
the threshold is no longer met. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting
in interim periods, disclosures, and transition.
Translation
of Foreign Currencies
For
subsidiaries where the functional currencies are
other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly
exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders’ equity, into U.S.
dollars. The Company records translation gains and losses in accumulated other comprehensive income (loss) as a component of
shareholders’ equity in the consolidated balance sheets.
SCHEDULE
OF TRANSLATION OF FOREIGN CURRENCIES
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Period-end RMB per USD exchange rate | |
| 6.8109 | | |
| 7.1636 | |
| Average RMB per USD exchange rate | |
| 6.8932 | | |
| 7.2526 | |
| | |
December 31, 2025 | |
| Period-end RMB per USD exchange rate | |
| 6.9937 | |
| Average yearly RMB per USD exchange rate | |
| 7.1862 | |
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Period-end HKD per USD exchange rate | |
| 7.8420 | | |
| 7.8499 | |
| Average HKD per USD exchange rate | |
| 7.8243 | | |
| 7.7924 | |
| | |
December 31, 2025 | |
| Period-end HKD per USD exchange rate | |
| 7.7832 | |
| Average yearly HKD per USD exchange rate | |
| 7.7959 | |
| Translation of Foreign Currencies Rate | |
| 7.7959 | |
The
RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions.
No representation is made that the RMB amounts could have been, or could be, converted into USD at the rates used in translation.
For
the six months ended June 30, 2026 and 2025 foreign currency translation adjustments of $(1,992) and $320 respectively, were reported
as other comprehensive income (loss) in the consolidated financial statements.
Other
Comprehensive Income
Other
comprehensive income is defined as the change in equity during the period from transactions and other events, excluding the changes resulting
from investments by owners and distributions to owners. Other comprehensive income is not included in the computation of income tax expense
or benefit. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.
Recent
Accounting Pronouncements
In
November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard update (“ASU”) 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances the disclosures required for segments,
primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and
included in each reported measure of segment profit or loss. The Company adopted ASU 2023-07. The adoption of this standard did not have
a material impact on the Company’s consolidated financial statements.
In
December 2023, the FASB issued a new standard, ASU 2023-09, to improve income tax disclosures. The guidance requires disclosure of disaggregated
income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other
income tax-related disclosures. The Company adopted ASU 2023-09. The adoption of this standard did not have a material impact on the Company’s
consolidated financial statements, as the amendments primarily relate to disclosures.
In
November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation
Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional disclosures about certain
expenses included in commonly presented expense captions on the statement of income. In January 2025, the FASB issued ASU 2025-01 to
clarify the interim effective date of ASU 2024-03. The amendments are effective for public business entities for annual reporting
periods beginning after December 15, 2026, and for interim reporting periods within annual reporting periods beginning after
December 15, 2027. Early adoption is permitted. The Company is
currently evaluating the impact of this standard on its consolidated
financial statement disclosures.
In July 2025,
the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable
and Contract Assets. The amendments provide a practical expedient for estimating expected credit losses on current accounts receivable
and current contract assets arising from transactions accounted for under Topic 606. The amendments are effective for annual reporting
periods, including interim periods within those annual periods, beginning after December 15, 2025. The Company adopted ASU 2025-05 effective
January 1, 2026. The adoption did not have a material impact on the Company’s consolidated financial statements.
In December
2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the applicability
of interim reporting guidance, consolidates interim disclosure requirements, and establishes a disclosure principle for material events
and changes occurring since the end of the most recent annual reporting period. The amendments are effective for public business entities
for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating
the impact of the amendments on its interim financial statement disclosures.
In December 2025, the FASB issued ASU 2025-12, Codification Improvements,
which makes clarifications, technical corrections and other incremental improvements to various Topics in the FASB Accounting Standards
Codification. The amendments are effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods
within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the impact of the amendments on
its consolidated financial statements and related disclosures.
Other
accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until
a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.
NOTE 2 – SEGMENT
REPORTING
The Company
operates as a single operating and reportable segment. The Company’s chief operating decision maker (“CODM”) is the
Chief Executive Officer. The CODM reviews the Company’s consolidated financial information in assessing performance and making decisions
regarding the allocation of resources.
The measure
of segment profit or loss used by the CODM is net income (loss), which is consistent with the corresponding measure presented
in the Company’s consolidated financial statements.The CODM uses net
income (loss) to evaluate the Company’s overall financial performance, monitor actual results against expectations, and make decisions
regarding the allocation of resources.
The following table presents revenues, significant segment expenses, other segment items, and the measure of segment
profit or loss that are regularly provided to the CODM for the periods presented:
SCHEDULE
OF REVENUES, SIGNIFICANT SEGMENT EXPENSES, OTHER SEGMENT ITEMS AND THE MEASURE OF SEGMENT PROFIT OR LOSS
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| Revenue | |
$ | 433,784 | | |
$ | 471,198 | |
| Cost of revenue | |
| 316,938 | | |
| 308,320 | |
| Selling and marketing | |
| 24,952 | | |
| 26,860 | |
| General and administrative | |
| 98,678 | | |
| 115,390 | |
| Interest income, net | |
| (38 | ) | |
| (25 | ) |
| Other expense, net | |
| 1,130 | | |
| 538 | |
| Other segment items | |
| - | | |
| - | |
| Net income (loss) | |
$ | (6,784 | ) | |
$ | 20,628 | |
Significant segment expenses presented above represent
the expense categories that are regularly provided to the CODM and are included in the measure of segment profit or loss used by the CODM
to assess performance and allocate resources.
Other segment items were $0 for the six months ended June 30, 2026 and 2025 because all items included in the measure
of segment net income (loss) that were significant and regularly provided to the CODM are separately disclosed above.
The Company has one reportable
segment and therefore the segment revenues and net income (loss) presented above are the same as the corresponding consolidated
amounts presented in the consolidated financial statements.
NOTE
3 – LEASES
The
Company’s lease portfolio primarily consisted of two office leases. One lease commenced on November 1, 2024 and expired on
October 31, 2025, and the other commenced on September 1, 2025 and expired on March 31, 2026. The Company accounted for these office
leases as short-term leases. As of June 30, 2026 and December 31, 2025, the Company had no right-of-use assets or lease liabilities
recorded on its consolidated balance sheets.
The
following table summarizes the lease costs recognized in the consolidated statements of earnings:
SCHEDULE
OF LEASE COST
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| Operating lease cost | |
$ | - | | |
$ | - | |
| Short-term lease cost | |
| 3,834 | | |
| 3,475 | |
| Variable lease cost | |
| - | | |
| - | |
| Total lease cost | |
$ | 3,834 | | |
$ | 3,475 | |
NOTE
4 – RELATED PARTY TRANSACTIONS
Due
to related parties
During
the six months ended June 30, 2026 and 2025, the Company borrowed an aggregate of $42,360 and $41,266, respectively, from Mr. Heng Fei Yang,
the Company’s CEO. The Company repaid $393,442 during the six months ended June 30, 2026 and $157,185 in the same period in 2025.
These loans are unsecured, interest-free, and repayable on demand. As of June 30, 2026 and December 31, 2025, the outstanding loan balance
was $196,268 and $537,724, respectively.
NOTE
5 – OTHER PAYABLES
As
of June 30, 2026 and December 31, 2025, the Company reported $36,030 and $80,589 as its other payables, respectively. Other payables
mainly consist of amounts due for professional services, including audit, legal, and financial reporting and filing services.
NOTE
6 – EQUITY
The
Company is authorized to issue 100,000,000 shares of common stock without par value. As of June 30, 2026 and December 31, 2025, it had
45,518,000 shares issued and outstanding.
On
July 13, 2022, the Company declared a reverse stock split to convert its outstanding common stock from 100,000,000 shares to 40,000,000
shares.
On
August 22, 2022, the Company issued 5
million shares to 66 individuals for RMB 3,400,700
or approximately $500,000.
The relevant subscription proceeds had
been collected in May and June 2022.
On
October 26, 2023, the Company sold 500,000 shares to Mr. Gang Wang for $100,000. Additionally, on December 25, 2023, the Company sold
18,000 shares to Mr. Lihong Zou for $7,200. The total of 518,000 shares from these transactions was issued in 2024.
NOTE
7 – TAXES
Income
Taxes
British
Virgin Islands (“BVI”)
Tian’an
is incorporated in BVI and is generally not subject to tax on income or capital gain under current BVI law. In addition, payments of dividends by
Tian’an to its shareholders are not subject to withholding tax in the BVI.
Hong
Kong
The
Company’s subsidiary, Tian’an HK, is incorporated in Hong Kong and had no taxable profit or income tax liabilities during
the period. Tian’an HK is subject to tax at 16.5%
on the assessable profits arising in or derived from Hong Kong.
The
PRC
The
Company’s subsidiaries
operating in the PRC are generally
subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%.
The reconciliation of income tax rate to the effective income tax rate for the six months ended June 30, 2026 and 2025 from
continuing operations is as follows:
SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| Income (loss) before income taxes from operations in the PRC | |
$ | (7,876 | ) | |
$ | 20,115 | |
| Statutory income tax rate | |
| 25 | % | |
| 25 | % |
| Income tax expense at statutory rate | |
| (1,969 | ) | |
| 5,029 | |
| Tax effect of net operating loss carryforward | |
| - | | |
| (5,029 | ) |
| Valuation allowance of deferred tax assets | |
| 1,969 | | |
| - | |
| Income tax expense | |
$ | - | | |
$ | - | |
Management
believes that it is more likely than not that the deferred tax assets will not be fully realizable in the future. Accordingly, the Company
recorded an increase of $1,969 in its valuation allowance against its deferred tax assets for the six months ended June 30, 2026,
primarily relating to net operating loss carryforwards from the local tax regime.
Value-Added
Tax and Other Withholding and Other Levies
The
Company’s products are sold in the PRC and are subject to VAT on the gross sales price. The VAT rates range up to 13%, depending
on the type of products sold. The VAT may be offset by VAT paid by the Company for raw materials and other materials included in the
cost of producing or acquiring its finished products. The Company records a VAT payable net of payments if the VAT payable on the gross
sales is larger than VAT paid by the Company on purchase of materials or finished goods: otherwise, the Company records a VAT deductible
in the accompanying financial statements net of any VAT payable at the end of reporting periods. As of June 30, 2026 and December 31,
2025, the Company recorded VAT payable of $2,693 and $4,959, respectively.
The
Company is also subject to various local government levies, including stamp tax, urban construction tax, and additional education tax.
The rates for these levies are minimal and vary across the different jurisdictions in which the Company operates. Additionally, the Company
serves as the withholding agent for personal income tax on employee salaries. As of June 30, 2026 and December 31, 2025, the Company
recorded $1,707 and $248 in other levies and tax withholdings.
NOTE
8 – EARNINGS (LOSS) PER SHARE
Basic
net earnings (loss) per share is computed using the weighted average number of common shares outstanding during the period. The dilutive
effect of potential common shares outstanding is included in diluted net earnings (loss) per share. The following table sets forth the
computation of basic and diluted net earnings (loss) per share for the six months ended June 30, 2026 and 2025:
SCHEDULE
OF BASIC AND DILUTED NET LOSS PER SHARE
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| Net income (loss) attributable to common shareholders | |
$ | (7,876 | ) | |
$ | 20,115 | |
| Weighted average common shares outstanding – Basic and diluted | |
| 45,518,000 | | |
| 45,518,000 | |
| Earnings (loss) per common share – basic and diluted | |
$ | (0.00 | ) | |
$ | 0.00 | |
NOTE
9 – STATUTORY RESERVES
Under
the laws of the PRC the Company’s subsidiaries are required to make appropriate at least 10% of their annual after-tax
profits, as determined in accordance with accounting principles generally accepted in the PRC (“PRC GAAP”), to a
statutory surplus reserve until the accumulated balance of such reserve reaches 50% of the respective subsidiary’s registered
capital. If a PRC subsidiary has accumulated losses from prior years, its current-year after-tax profits are first used to offset
such accumulated losses before any appropriation to the statutory surplus reserve is made.
The statutory surplus reserve may be used to offset
accumulated losses, expand the subsidiary’s business operations, or increase its registered capital in accordance with applicable
PRC laws and regulations. Amounts appropriated to the statutory surplus reserve are generally not available for distribution as cash dividends.
The
statutory surplus reserves of the Company’s PRC subsidiaries were $0 and
$0 as
of June 30, 2026 and December 31, 2025.
NOTE
10 – CONCENTRATIONS OF RISK
The
Company is exposed to the following concentration risks:
| a. | Credit
risk and major customers |
Financial
instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration
of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection
terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful
accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.
As
of June 30, 2026 and December 31, 2025, substantially all of the Company’s cash including cash on hand and deposits in
accounts were maintained with financial institutions in the PRC and Hong Kong. Eligible deposits maintained with participating PRC
banking institutions are generally covered under the PRC deposit insurance system up to the applicable statutory limit. Cash
balances in excess of applicable deposit insurance limits, as well as balances not otherwise covered by applicable deposit
protection arrangements, are subject to credit risk. However, the Company has not experienced any such losses and believes it is not
exposed to any significant risks on its cash in bank accounts.
The
Company’s key customers are located in the PRC. The Company has not entered into long-term supply contracts with any of these major
customers. During the six months ended June 30, 2026 and 2025, the Company’s customers that accounted for 10% or more of the Company’s
revenue were as follows:
SCHEDULE
OF CONCENTRATION OF RISK
| Customers | |
2026 | | |
2025 | |
| | |
For the Six Months Ended
June 30, | |
| Customers | |
2026 | | |
2025 | |
| A | |
| - | | |
| 33 | % |
| B | |
| - | | |
| 25 | % |
| C | |
| 17 | % | |
| 20 | % |
| D | |
| 10 | % | |
| - | |
| E | |
| 16 | % | |
| - | |
| F | |
| 14 | % | |
| - | |
Suppliers
that accounted for 10% or more of the Company’s purchases during the six
months ended June 30, 2026 and 2025
were as follows:
| Suppliers | |
2026 | | |
2025 | |
| | |
For the Six Months Ended
June 30, | |
| Suppliers | |
2026 | | |
2025 | |
| AA | |
| 99 | % | |
| 79 | % |
| BB | |
| 1 | % | |
| 21 | % |
| Concentration risk percentage | |
| 1 | % | |
| 21 | % |
As
the Company has no significant interest-bearing assets or liabilities, the Company’s income and operating cash flows are substantially
independent of changes in market interest rates.
The
Company reports its financial statements in U.S. dollars (USD). However, the majority of its revenues and costs are denominated in Chinese
Renminbi (RMB), and a significant portion of its assets and liabilities are also held in RMB. As a result, the Company is exposed to
foreign exchange risk, as fluctuations in the exchange rate between USD and RMB may impact its revenues and financial results. A depreciation
of RMB against USD would reduce the value of RMB-denominated revenues and assets when translated into USD.
The
Company does not currently use any derivative or other financial instruments that would expose it to substantial market risk.
| d. | Economic
and political risks |
The
Company’s operations are primarily conducted in the PRC. Accordingly, the Company’s business, financial condition and
results of operation may be influenced by changes in the political, economic, legal and regulatory environment in the PRC, as well as by
changes in general economic conditions. A slowdown in economic growth, changes in consumer demand or changes in laws, regulations or governmental policies applicable
to the Company’s business could adversely affect the Company’s operations and financial performance.
The Company is also subject to risks associated with foreign currency exchange, currency conversion and remittance
restrictions, taxation, regulatory changes and other governmental policies applicable to companies operating in the PRC.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| Date:
August 20, 2026 |
TIAN’AN
TECHNOLOGY GROUP LTD |
| |
|
|
By: |
/s/
Heng Fei Yang |
| |
Name: |
Heng
Fei Yang |
| |
Title: |
Chief
Executive Officer |